Alongside the pro-inflammatory characteristics of systemic platelets, elevated levels of vWF circulating in MASLD patients may offer insight into the linkage between low-grade systemic inflammation and heightened CV risk within this population [82]. Here, VWF is linked to metabolic dysfunction-associated steatotic liver disease.